BIOMAT Database Logo BIOMAT Database Logo

[Fundamental and clinical studies on cefmenoxime in the field of pediatrics]. 1982

Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females

Related Publications

Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical evaluations of cefmenoxime in the field of pediatrics].
November 1982, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Clinical studies with cefmenoxime in the field of pediatrics].
October 1982, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on ceftazidime in the field of pediatrics].
March 1984, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on aspoxicillin in the field of pediatrics].
July 1985, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on cefuzonam in the field of pediatrics].
February 1987, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on cefminox in the field of pediatrics].
March 1985, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on cefminox in the field of pediatrics].
March 1985, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Fundamental and clinical studies on cefmenoxime in perinatal period].
December 1989, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Clinical studies on cefmenoxime in pediatric field].
October 1982, The Japanese journal of antibiotics,
Y Toyonaga, and M Sugita, and G Kawamura, and Y Kurosu, and K Horiuchi, and M Hori, and S Kohno, and O Tatsusawa, and T Takahashi
[Clinical studies on cefmenoxime in pediatric field].
October 1982, The Japanese journal of antibiotics,
Copied contents to your clipboard!